Cardiology Department and Cardiac Catheterization Laboratory, Athens General Hospital G. Gennimatas, Athens, Greece.
JACC Cardiovasc Interv. 2013 Mar;6(3):267-73. doi: 10.1016/j.jcin.2012.11.005.
The aim of this study was to test the hypothesis that moderate procedural sedation can reduce the incidence of radial artery spasm.
Transradial access for left heart catheterization and percutaneous coronary intervention is increasingly used for emergent and elective procedures, in lieu of the femoral approach. However, increased rates of access site crossover have been reported, with radial artery spasm being a major contributor to this effect.
Patients undergoing elective transradial percutaneous coronary intervention were prospectively randomized to receive fentanyl and midazolam during the procedure or no treatment (control subjects). The primary endpoint was angiographically confirmed radial artery spasm. Patient discomfort was quantified with a visual analogue scale.
Two thousand thirteen patients (age 64.5 ± 8.4 years) were randomized. Spasm occurred in 2.6% of the treatment group versus 8.3% of control subjects (p < 0.001; odds ratio [OR]: 0.29). The number needed to treat to avoid 1 case of spasm was 18 (95% confidence interval [CI]: 12.9 to 26.6). The access site crossover rate was 34% lower in the treatment group: 9.9% versus 15.0% (OR: 0.62; 95% CI: 0.48 to 0.82). Patient discomfort visual analogue scale score was 18.8 ± 12.5 in the treatment group versus 27.4 ± 17.4 in control subjects (p < 0.001). No significant differences were observed in the 30-day rate of death or repeat hospital stay for any cause: 4.6% versus 4.5% (OR: 1.02; 95% CI: 0.67 to 1.56).
Routine administration of relatively low doses of an opioid/benzodiazepine combination during transradial interventional procedures is associated with a substantial reduction in the rate of spasm, the need for access site crossover, and the procedure-related level of patient discomfort.
本研究旨在验证以下假设,即适度的程序镇静可降低桡动脉痉挛的发生率。
经桡动脉入路进行左心导管检查和经皮冠状动脉介入治疗(PCI)越来越多地用于急诊和择期手术,以替代股动脉入路。然而,已有报道称,入路部位的交叉率增加,其中桡动脉痉挛是主要原因。
前瞻性随机分配接受择期经桡动脉 PCI 的患者在手术期间接受芬太尼和咪达唑仑或不接受治疗(对照组)。主要终点是经血管造影证实的桡动脉痉挛。患者不适程度通过视觉模拟量表进行量化。
共随机分配了 2013 名患者(年龄 64.5±8.4 岁)。治疗组痉挛发生率为 2.6%,对照组为 8.3%(p<0.001;比值比[OR]:0.29)。避免 1 例痉挛的治疗人数为 18 人(95%置信区间[CI]:12.9 至 26.6)。治疗组的入路部位交叉率降低了 34%:9.9%比 15.0%(OR:0.62;95% CI:0.48 至 0.82)。治疗组患者不适视觉模拟量表评分为 18.8±12.5,对照组为 27.4±17.4(p<0.001)。30 天内的死亡率或因任何原因再次住院率无显著差异:4.6%比 4.5%(OR:1.02;95% CI:0.67 至 1.56)。
在经桡动脉介入治疗期间常规给予相对低剂量的阿片类药物/苯二氮䓬类药物联合治疗,可显著降低痉挛发生率、入路部位交叉需求以及与手术相关的患者不适程度。